R&D Investments and Technological Advancements to Boost the Growth of the Global Campylobacter Diagnosis Market
Transparency Market Research in its new report titled, “Campylobacter Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” provides key insights on the campylobacter diagnosis market. The upcoming report anticipates that the R&D investments and technological advancements will boost the growth of the global campylobacter diagnosis market. According to the TMR report, the global campylobacter diagnostics market is driven by several factors such as rise in population, sense of hygiene, diagnosis rate, cost of campylobacter infection diagnostic test, health care expenditure scenario, and presence of key market players. The report also anticipates that this market is likely to face challenges from sequencing of genetic materials of campylobacter infection, and un-automated data analysis during campylobacter detection method.
TMR mentions that the culture-based detection method is used to isolate and detect campylobacter infection from the sample. This method is cost-effective and requires no sophisticated instrument; however, it is time-consuming and has low-sensitivity. Rapid detection tests such as immunological or molecular techniques offer accurate result of campylobacter bacteria, although those tests are expensive as compared to culture based detection. Based on diagnosis method, the global campylobacter diagnosis market can be segmented into culture based diagnosis and rapid detection tests. Furthermore, the rapid detection tests can be segmented into immunological, molecular, and other methods. In terms of end-user, the market can be classified into hospitals, private laboratories, independent physician chambers, and others.
Based on the regional perspective, the report has segmented the global campylobacter diagnostics market into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Significant infection rate, high diagnosis rate of campylobacter infection, well-established health care infrastructure, availability of medical reimbursement, and strong presence of key companies are likely to boost the growth of North America and Europe campylobacter diagnostics market in future. On the other hand, high number of campylobacter infected cases, developing medical infrastructure, high investment, and presence of key companies in Asia Pacific will drive the campylobacter diagnostics market in the region. Low awareness about campylobacter infection diagnosis and unfavorable medical reimbursements are the factors attributed to sluggish growth of the market in Latin America and Middle East & Africa.
The report has included some of the key players in the global campylobacter diagnostics market to give a better competitive analysis and these include Dickinson and Company, Becton, Inc., Thermo Fisher Scientific, Meridian Bioscience, Agilent Technologies, BIOTECON Diagnostics, QIAGEN, Roche Molecular Systems, Inc., Alere, Siemens Healthineers, Lonza, ZeptoMetrix, and Sequenom.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
